Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medco Downplays Competition From Health Plans’ In-House PBMs

Executive Summary

Pharmacy benefit manager subsidiaries of large health insurers lack the scale and capability to provide the kinds of cost benefits and services offered by the big stand-alone PBMs, Medco Health Solutions Chairman David Snow maintains

You may also be interested in...

Vytorin/Zetia Rx Decline Prompts Schering-Plough To Issue Monthly Updates

Schering-Plough says it will soon start providing monthly updates on prescription rates for its two cholesterol drugs Vytorin (ezetimibe/simvastatin) and Zetia (ezetimibe) to help ease the minds of anxious investors

Warfarin Dosing Issues Emerge In Early Results From Medco/Mayo Research

Nearly three-fourths of early patient participants in a warfarin research project appear to need non-standard dosing of the drug based on genetic screening, Medco reported during its analyst day presentation Nov. 16

Medco PolyMedica Acquisition Expands Medicare Foothold Into Part B

Medco will establish a presence in Medicare Part B with its $1.5 billion purchase of diabetes services provider PolyMedica

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts